Red yeast rice interaction with other meds
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Here is a comprehensive summary of red yeast rice (RYR) drug interactions drawn from the medical literature:
Red Yeast Rice (RYR) — Drug Interactions
What Is Red Yeast Rice?
Red yeast rice is a fermentation product of rice with Monascus purpureus. It contains monacolin K, which is chemically identical to lovastatin, along with other statin-like monacolins. Because its statin content is variable and some preparations contain the nephrotoxin citrinin, it is generally not recommended as a substitute for prescription statins. — Katzung's Basic and Clinical Pharmacology, 16th ed.
Key Drug Interactions
RYR carries the same interaction profile as prescription statins (especially lovastatin). The primary risk with all interactions below is myopathy and rhabdomyolysis.
1. CYP3A4 Inhibitors — Elevated Statin Levels → Myopathy Risk
The monacolin K in RYR is metabolized by CYP3A4. Drugs that inhibit this enzyme raise RYR statin concentrations significantly:
| Drug Class | Examples |
|---|---|
| Macrolide antibiotics | Erythromycin, clarithromycin |
| Azole antifungals | Ketoconazole, itraconazole |
| Calcineurin inhibitors | Cyclosporine, tacrolimus (less so) |
| HIV protease inhibitors | Ritonavir, lopinavir, others |
| Antidepressants | Nefazodone |
| Antiarrhythmics | Amiodarone, verapamil |
Cyclosporine is especially notable — it both inhibits CYP3A4 and blocks hepatic uptake transporter OATP1B1, causing several-fold increases in statin blood levels. — Goodman & Gilman's, Katzung's, Comprehensive Clinical Nephrology
2. Gemfibrozil — Doubled Plasma Levels
Gemfibrozil inhibits OATP1B1-mediated hepatic uptake and glucuronidase-mediated statin metabolism, nearly doubling plasma statin concentrations — the combination most commonly implicated in statin-induced myopathy. Fenofibrate is preferred if a fibrate is needed alongside any statin or RYR. — Goodman & Gilman's, Katzung's
3. Niacin (Nicotinic Acid) — Pharmacodynamic Interaction
Niacin combined with statin activity enhances inhibition of skeletal muscle cholesterol synthesis — a pharmacodynamic myopathy risk independent of drug levels. The FDA withdrew approval of statin/niacin combination products in 2016. — Goodman & Gilman's
4. Other Statins
Taking RYR alongside a prescription statin is effectively double-dosing a statin — substantially increasing myopathy and hepatotoxicity risk.
5. CYP3A4 Inducers — Reduced Efficacy
Drugs that upregulate CYP3A4 reduce statin activity from RYR:
- Rifampin, phenytoin, barbiturates, griseofulvin, thiazolidinediones — Katzung's
6. Hepatotoxic Drugs
RYR itself is associated with hepatotoxicity. Concurrent use of other hepatotoxic agents (kava, chaparral, valerian, alcohol, azole antifungals) compounds liver injury risk. — Berek & Novak's Gynecology
7. Grapefruit Juice
Large daily amounts of grapefruit juice inhibit intestinal CYP3A4, raising monacolin K plasma levels — parallel to the known interaction with lovastatin. — Katzung's
Summary of Risks
| Interaction | Mechanism | Clinical Risk |
|---|---|---|
| CYP3A4 inhibitors (cyclosporine, macrolides, azoles, protease inhibitors) | Reduced statin metabolism | Myopathy, rhabdomyolysis |
| Gemfibrozil | OATP1B1 inhibition + glucuronidase inhibition | Myopathy, rhabdomyolysis |
| Niacin | Pharmacodynamic synergy | Myopathy |
| Other statins | Additive statin activity | Myopathy, hepatotoxicity |
| Hepatotoxic drugs/herbs | Additive liver toxicity | Hepatotoxicity |
| CYP3A4 inducers | Increased statin metabolism | Reduced lipid-lowering efficacy |
| Grapefruit juice | Intestinal CYP3A4 inhibition | Elevated statin levels |
Clinical Bottom Line
- RYR should not be used with prescription statins, gemfibrozil, niacin, cyclosporine, macrolide antibiotics, azole antifungals, or HIV protease inhibitors without careful risk-benefit evaluation.
- If myopathy is suspected (muscle pain/weakness), check CK immediately and discontinue RYR.
- RYR should be stopped 2–3 weeks before elective surgery due to hepatotoxic and pharmacokinetic concerns.
- Because its statin content is unregulated and variable, it is harder to predict or manage these interactions compared to prescription statins.
This is a shared conversation. Sign in to Orris to start your own chat.